Io Therapeutics Alternatives & Competitors
12 companies similar to Io Therapeutics — Io therapeutics focuses on developing drugs that target nuclear receptors in ord...
Companies similar to Io Therapeutics
Yantai, China
Odyssey Therapeutics
Building a machine learning-based platform to develop novel therapeutics focusing on cance...
Century Therapeutics, Inc
Advancing iPSC-derived cell therapies to transform care in autoimmune disease and cancer
Philadelphia, United Stat...
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Track all Io Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T thera...
South San Francisco, Unit...
Belgium
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Gaithersburg, United Stat...
Myrobalan Therapeutics
Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS...
Medford, United States
Pinteon Therapeutics
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...
About Io Therapeutics
Io Therapeutics is a biotechnology company renowned for its focus on developing drugs that target nuclear receptors. Their innovative approach aims to address significant health challenges, including cancer, neurodegenerative diseases, and autoimmune disorders. Founded in 2010, the company operates out of Santa Ana, CA...
Therapeutic compound discovery, Development of nuclear receptor-targeted drugs, Research and development in immuno-oncology, Management of drug development pipeline
Healthcare professionals, Oncologists, Neurologists, Patients with cancer, Patients with neurodegenerative diseases, Patients with autoimmune diseases, Pharmaceutical researchers
Biopharmaceuticals, Nuclear Receptors, Drug Development, Cancer Treatment, Neurodegenerative Disorders, Autoimmune Diseases, Therapeutic Compounds, Drug Research, Private Company, Therapeutic Innovation, Medical Conditions, Santa Ana, Houston
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Io Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Io Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 17 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
